These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 31576841

  • 1. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C, Guan R, Liao X, Ouyang C, Rees TW, Liu J, Chen Y, Ji L, Chao H.
    Chem Commun (Camb); 2019 Oct 25; 55(83):12547-12550. PubMed ID: 31576841
    [Abstract] [Full Text] [Related]

  • 2. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J, Bermejo-Casadesus C, Zafon E, Martínez-Alonso M, Durá G, Heras A, Soriano-Díaz I, Giussani A, Ortí E, Tebar F, Espino G, Massaguer A.
    Eur J Med Chem; 2024 Oct 05; 276():116618. PubMed ID: 38972079
    [Abstract] [Full Text] [Related]

  • 3. Ir(III) and Ru(II) Complexes in Photoredox Catalysis and Photodynamic Therapy: A New Paradigm towards Anticancer Applications.
    Raza MK, Noor A, Samantaray PK.
    Chembiochem; 2021 Dec 02; 22(23):3270-3272. PubMed ID: 34558773
    [Abstract] [Full Text] [Related]

  • 4. A Multi-action and Multi-target RuII -PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.
    Karges J, Yempala T, Tharaud M, Gibson D, Gasser G.
    Angew Chem Int Ed Engl; 2020 Apr 27; 59(18):7069-7075. PubMed ID: 32017379
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
    Lin M, Zou S, Liao X, Chen Y, Luo D, Ji L, Chao H.
    Chem Commun (Camb); 2021 May 04; 57(36):4408-4411. PubMed ID: 33949487
    [Abstract] [Full Text] [Related]

  • 8. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N, Feng Y, Sun W, Lu J, Lu S, Yao Y, Li C, Wang X, Zhou Q.
    Dalton Trans; 2019 May 15; 48(19):6492-6500. PubMed ID: 30994660
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J, Tian M, Tian Z, Zhang S, Yan C, Shao C, Liu Z.
    Inorg Chem; 2018 Feb 19; 57(4):1705-1716. PubMed ID: 29400963
    [Abstract] [Full Text] [Related]

  • 12. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S, Zhao J, Wang X, Xu G, Gou S, Zhao Q.
    Inorg Chem; 2020 Aug 03; 59(15):11193-11204. PubMed ID: 32702972
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J, Tian Z, Xu Z, Zhang S, Feng Y, Zhang L, Liu Z.
    Dalton Trans; 2018 Nov 13; 47(44):15772-15782. PubMed ID: 30357192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
    Chen L, Wang J, Cai X, Chen S, Zhang J, Li B, Chen W, Guo X, Luo H, Chen J.
    Bioorg Chem; 2022 Feb 13; 119():105516. PubMed ID: 34856444
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.
    Koch V, Meschkov A, Feuerstein W, Pfeifer J, Fuhr O, Nieger M, Schepers U, Bräse S.
    Inorg Chem; 2019 Dec 02; 58(23):15917-15926. PubMed ID: 31714764
    [Abstract] [Full Text] [Related]

  • 19. Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
    Liu C, Xiang J, Xiang C, Li H.
    Bioorg Chem; 2021 Sep 02; 114():105142. PubMed ID: 34243072
    [Abstract] [Full Text] [Related]

  • 20. Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy.
    Zhang P, Huang H, Banerjee S, Clarkson GJ, Ge C, Imberti C, Sadler PJ.
    Angew Chem Int Ed Engl; 2019 Feb 18; 58(8):2350-2354. PubMed ID: 30552796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.